Article Text
Abstract
The trend towards postponement of childbearing has seen increasing numbers of women turning towards oocyte banking for anticipated gamete exhaustion (AGE banking), which offers a realistic chance of achieving genetically connected offspring. However, there are concerns around the use of this technology, including social/ethical implications, low rate of utilisation and its cost-effectiveness. The same societal trends have also resulted in an increased demand and unmet need for donor oocytes, with many women choosing to travel overseas for treatment. This has its own inherent social, medical, financial and psychological sequelae. We propose a possible pathway to address these dual realities. The donation of oocytes originally stored in the context of AGE banking, with appropriate compensatory mechanisms, would ameliorate AGE banking concerns, while simultaneously improving the supply of donor oocytes. This proposed arrangement will result in tangible benefits for prospective donors, recipients and society at large.
- in vitro fertilisation and embryo transfer
- donation/procurement of organs/tissues
- allocation of health care resources
- cryobanking of sperm, ova or embryos
Statistics from Altmetric.com
Footnotes
Contributors Both authors substantially contributed to the concept, writing and revision, and final preparation of this manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement All data relevant to the study are included in the article.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Read the full text or download the PDF:
Other content recommended for you
- Preservation of fertility in adults and children diagnosed with cancer
- The need for donor consent in mitochondrial replacement
- Effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilisation in women with high antral follicle count: study protocol for a randomised controlled trial
- The Uppsala – Stockholm Assisted Reproductive Techniques (UppStART) study
- Occupational factors and markers of ovarian reserve and response among women at a fertility centre
- Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI - ICSI): protocol for a multicentre randomised controlled trial
- What constitutes a reasonable compensation for non-commercial oocyte donors: an analogy with living organ donation and medical research participation
- A brief and personal history of ‘ what ’s in a name ’ in reproductive genetics
- Simvastatin Effects on Androgens, Inflammatory Mediators, and Endogenous Pituitary Gonadotropins Among Patients With PCOS Undergoing IVF
- Live birth after in vitro maturation versus standard in vitro fertilisation for women with polycystic ovary syndrome: protocol for a non-inferiority randomised clinical trial